Pfizer Trial of Lung Cancer Treatment Lorlatinib Seen as ‘Clinically Meaningful’

Pfizer Trial of Lung Cancer Treatment Lorlatinib Seen as ‘Clinically Meaningful’

Pfizer (PFE) said on Monday that a Phase 2 clinical trial for lorlatinib, a treatment for lung cancer patients and secondary malignant tumors on the brain, indicated meaningful activity. The drugmaker said the study examined the activity and safety of lorlatinib in 275 patients with or without asymptomatic, untreated or treated brain metastases. A metastatic growth is secondary malignant growth at a distance from a primary site of cancer. “Controlling […]

Read More ˃
Saudi Stocks Advance on Higher Oil Prices, Stronger Banks

Saudi Stocks Advance on Higher Oil Prices, Stronger Banks

MidEast shares were mixed, with Saudi Arabia rising on the back of higher oil prices on signs of less tension between Baghdad and Iraqi Kurdistan. Banks also lent support after Alinma Bank said Q3 net profits rose to 542 million riyals ($145 million) from 312 million riyals a year ago and above the average analyst forecast for 493 million riyals. However, weaker Egyptian banks pressured that country’s main index. Investors […]

Read More ˃
GoC Yields Tip Back Towards Session Lows

GoC Yields Tip Back Towards Session Lows

GoC yields tipped back towards session lows alongside Treasuries, as risk assets were further underpinned following news U.S. President Donald Trump plans to decertify the Iran nuclear pact. Treasury yields had plunged early in the session on the tame core consumer price index print, with GoCs following suit. The S&P/TSX continues to outperform Wall Street thanks to firmer crude oil prices, up 0.5% compared to 0.2% gains for the Dow […]

Read More ˃
Goldman Reportedly Is Looking Into Options for Its Less Than $1 Mln Stake in Harvey Weinstein’s Film Studio

Goldman Reportedly Is Looking Into Options for Its Less Than $1 Mln Stake in Harvey Weinstein’s Film Studio

Goldman Sachs (GS) is weighing its options for its less-than $1 million stake in Weinstein and Co., Harvey Weinstein’s film studio that it co-founded with his brother Bob, Bloomberg reported, citing the Wall Street bank’s spokesman Andrew Williams. Harvey Weinstein was sacked from the studio after allegations that he had sexually harassed and assaulted women over decades, according to recent news reports. Goldman was an initial investor in the studio […]

Read More ˃
Forum Energy Cuts Q3 Outlook Due to Harvey Impact

Forum Energy Cuts Q3 Outlook Due to Harvey Impact

Forum Energy Technologies (FET) said Thursday that its Q3 financial results were adversely impacted by Hurricane Harvey’s widespread damage in Texas and Louisiana, and now expects revenues of approximately $200 million and adjusted net loss of $0.10 per share for the quarter. The company previously issued net loss guidance of $0.07 to $0.04 loss per share, on sequential revenue growth of 8% to 12%. Analysts polled by Capital IQ have […]

Read More ˃
Micron Technology Prices Upsized Offering of 29.3 Mln Shares at 1.5% Discount

Micron Technology Prices Upsized Offering of 29.3 Mln Shares at 1.5% Discount

Micron Technology (MU) said late Wednesday it has priced the sale of 29.3 million shares in a public offering at $41 each, a 1.5% discount to the closing price. The offering was upsized to $1.2 billion from previously $1 billion. Micron also granted the underwriter an option to buy an additional 4.4 million shares. The company said it plans to use approximately $476 million of the net proceeds to redeem […]

Read More ˃
Protagonist Therapeutics Prices Offering of 3.5 Mln Shares at 14.2% Discount

Protagonist Therapeutics Prices Offering of 3.5 Mln Shares at 14.2% Discount

Protagonist Therapeutics (PTGX) said late Wednesday it has priced the public offering of more than 3.5 million shares at $17 each, a 14.2% discount to the closing price. The company has also granted underwriters a 30-day option to buy an additional 529,500 shares. Gross proceeds are expected to be $60 million and Protagonist said it plans to use net proceeds to fund clinical research and development of the company’s three […]

Read More ˃
Globalstar to Sell $125 Mln in Shares of Voting Common Stock

Globalstar to Sell $125 Mln in Shares of Voting Common Stock

Globalstar (GSAT), a provider of mobile satellite voice and data services, said after market close on Wednesday that it has begun an offering of $125 million in shares of voting common stock in a registered underwritten public offering. Globalstar will grant the underwriters a 30-day option to buy up to $18.75 million in additional shares of voting common stock. This offering is made to satisfy a requirement relating to the […]

Read More ˃